Mesoatrial shunt in Budd-Chiari syndrome

被引:20
作者
Emre, A
Kalayci, G
Özden, I
Bilge, O
Acarli, K
Kaymakoglu, S
Rozanes, I
Ökten, A
Tekant, Y
Alper, A
Ariogul, O
机构
[1] Univ Istanbul, Istanbul Fac Med, Dept Gastroenterol, Istanbul, Turkey
[2] Univ Istanbul, Istanbul Fac Med, Dept Radiol, Istanbul, Turkey
[3] Univ Istanbul, Istanbul Fac Med, Dept Gen Surg, Istanbul, Turkey
[4] Univ Istanbul, Istanbul Fac Med, Hepatopancreatobiliary Surg Unit, Istanbul, Turkey
关键词
D O I
10.1016/S0002-9610(00)00335-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The operations with proven effects on survival in Budd-Chiari syndrome are shunt operations and liver transplantation. PATIENTS AND METHODS: Between 1993 and 1999 (June), 13 cases of Budd-Chiari syndrome have been treated surgically. Four cases had concomitant thrombosis of the inferior vena cava; the others had marked narrowing of the lumen due to the enlarged caudate lobe. Mesoatrial (n = 12) or mesosuperior vena caval (n = 1) shunts were constructed with ringed polytetrafluoroethylene grafts. RESULTS: The median portal pressure fell from 45 (range 32 to 55) to 20 (range 11 to 27) cm H2O (P <0.001). Two patients died in the early postoperative period. One patient who did not comply with anticoagulant treatment had a shunt thrombosis in the second postoperative year. The other 10 patients are alive without problems during a median 42 (range 1 to 76) months of follow-up. CONCLUSION: Mesoatrial shunt with a ringed polytetrafluoroethylene graft is effective in Budd-Chiari syndrome cases with thrombosis or significant stenosis in the inferior vena cava. Am J Surg. 2000;179:304-308. (C) 2000 by Excerpta Medica, Inc.
引用
收藏
页码:304 / 308
页数:5
相关论文
共 39 条
[1]  
ACARCH K, 1999, CLIN EX SURG ISTANBU, V7, P61
[2]   SELECTIVE SURGICAL THERAPY OF THE BUDD-CHIARI SYNDROME PROVIDES SUPERIOR SURVIVOR RATES THAN CONSERVATIVE MEDICAL-MANAGEMENT [J].
AHN, SS ;
YELLIN, A ;
SHENG, FC ;
COLONNA, JO ;
GOLDSTEIN, LI ;
BUSUTTIL, RW .
JOURNAL OF VASCULAR SURGERY, 1987, 5 (01) :28-37
[3]   PORTASYSTEMIC SHUNTING VERSUS LIVER-TRANSPLANTATION FOR THE BUDD-CHIARI SYNDROME [J].
BISMUTH, H ;
SHERLOCK, DJ .
ANNALS OF SURGERY, 1991, 214 (05) :581-589
[4]   BUDD-CHIARI SYNDROME - TECHNICAL, HEMODYNAMIC, AND CLINICAL-RESULTS OF TREATMENT WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT [J].
BLUM, U ;
ROSSLE, M ;
HAAG, K ;
OCHS, A ;
BLUM, HE ;
HAUENSTEIN, KH ;
ASTINET, F ;
LANGER, M .
RADIOLOGY, 1995, 197 (03) :805-811
[5]   De novo hepatic tumors following portocaval shunt for Budd-Chiari syndrome [J].
Braun, F ;
Nolte, W ;
Lorf, T ;
Canelo, R ;
Sattler, B ;
Müller, D ;
Vosshenrich, R ;
Ramadori, G ;
Ringe, B .
CHIRURGISCHE GASTROENTEROLOGIE, 1998, 14 (04) :318-322
[6]   MESOATRIAL SHUNT - NEW TREATMENT FOR BUDD-CHIARI SYNDROME [J].
CAMERON, JL ;
MADDREY, WC .
ANNALS OF SURGERY, 1978, 187 (04) :402-406
[7]  
CAMERON JL, 1984, SURGERY, V96, P114
[8]   THE BUDD-CHIARI SYNDROME - TREATMENT BY MESENTERIC-SYSTEMIC VENOUS SHUNTS [J].
CAMERON, JL ;
HERLONG, HF ;
SANFEY, H ;
BOITNOTT, J ;
KAUFMAN, SL ;
GOTT, VL ;
MADDREY, WC .
ANNALS OF SURGERY, 1983, 198 (03) :335-346
[9]  
CAMPBELL DA, 1988, SURG GYNECOL OBSTET, V166, P511
[10]  
CAMPBELL DA, 1995, CURRENT SURG THERAY, P338